🧪
hypothesis

DRP1 S616 Hyperphosphorylation and MFN2 Downregulation Create a Vicious Cycle Driving Mitochondrial Fission-Fusion Imbalance and Neuronal Senescence

Hypothesis

DRP1 S616 Hyperphosphorylation and MFN2 Downregulation Create a Vicious Cycle Driving Mitochondrial Fission-Fusion Imbalance and Neuronal Senescence

Neuronal mitochondrial dynamics are uniquely governed by the opposing activities of fission (DRP1-mediated) and fusion (MFN1/MFN2-mediated) proteins, with the balance critically determining mitochondrial morphology, distribution, and fun.
🧬 DRP1,MFN1,MFN2,CDK5,PRKCD,PARK2,PTEN,PGC1A,OPA1🩺 neurodegeneration🎯 Composite 68%💱 $0.54▼2.3%proposed
EvidencePending (0%)📖 5 cit🗣 1 debates 5 support 2 oppose
⚠ Orphaned Senate Quality Gates →
🏆 ChallengeResolve: DRP1/MFN2 Mitochondrial Dynamics Imbalance in Neurodegeneration$500 →
☰ Compare⚛️ Collide
📄 Export LaTeX
arXiv PreprintNeurIPSNature MethodsPLOS ONE
📖 Export BibTeXinteract with this hypothesis
Composite68%

🧪 Overview

Neuronal mitochondrial dynamics are uniquely governed by the opposing activities of fission (DRP1-mediated) and fusion (MFN1/MFN2-mediated) proteins, with the balance critically determining mitochondrial morphology, distribution, and functional quality. This hypothesis proposes that in neurodegeneration-associated senescence, chronic DRP1 S616 hyperphosphorylation (driven by CDK5 and PKCδ activation) shifts the fission-fusion balance toward excessive fragmentation, producing small, depolarized mitochondria that cannot efficiently meet neuronal ATP demands. Simultaneously, MFN2 is downregulated at both transcriptional and protein levels through p53-mediated repression of the MFN2 promoter, further impairing fusion capacity. The resulting mitochondrial fragmentation triggers a senescence-associated metabolic phenotype characterized by reduced oxidative phosphorylation (Complex I activity <40% of controls), compensatory glycolytic shift (2-fold increase in lactate production), and ROS overproduction (mtROS levels 3-4× above baseline).

...

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

flowchart TD
    A["CDK5 and PKCdelta Activation<br/>Senescence-Associated Kinase Surge"]
    B["DRP1 Ser616 Hyperphosphorylation<br/>Fission Machinery Overactivated"]
    C["p53 Stabilization<br/>MFN2 Promoter Repression"]
    D["MFN2 Protein Downregulated 60 percent<br/>Fusion Capacity Impaired"]
    E["Mitochondrial Fragmentation<br/>Small Depolarized Mitochondria"]
    F["Complex I Activity Below 40 percent<br/>Glycolytic Shift and ROS Overproduction"]
    G["Parkin Recruitment Fails<br/>Impaired Mitophagic Elimination"]
    H["ROS Feedforward Loop<br/>Further DRP1 Activation"]
    I["Neuronal Senescence<br/>AD CA1 Neuron Degeneration"]
    A --> B
    A --> C
    C --> D
    B --> E
    D --> E
    E --> F
    E --> G
    F --> H
    G --> H
    H --> B
    F --> I
    G --> I
    style E fill:#7b1fa2,stroke:#ce93d8,color:#ce93d8
    style I fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a

⚖️ Evidence

⚖️ Evidence Matrix5 supports0 contradicts
Supports
Molecular mechanisms of mitochondrial dynamics.
Nat Rev Mol Cell Biol2025PMID:39420231medium
Supports
Drp1-dependent mitochondrial fission in cardiovascular disease.
Acta Pharmacol Sin2021PMID:32913266medium
Supports
Mitochondrial dynamics in health and disease.
FEBS Lett2021PMID:33742459medium
Supports
Neuropathic Pain: the Dysfunction of Drp1, Mitochondria, and ROS Homeostasis.
Neurotox Res2020PMID:32696439medium
Supports
Mitochondrial dynamics in type 2 diabetes: Pathophysiological implications.
Redox Biol2017PMID:28131082medium
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — DRP1

No curated PDB or AlphaFold mapping for DRP1 yet. Search RCSB →

💉 Clinical Trials (5)Relevance: 78%

0
Active
0
Completed
0
Total Enrolled
NA
Highest Phase
Autophagy and Inflammasome in Obesity: Effect of Weight Loss and Potential Therapeutic ImplicationsUnknown
COMPLETED·NCT05071391 · Milagros Rocha Barajas
Obesity
Roux-en-Y gastric bypass
Gut Microbiota, Mitochondrial Function and Metabolic Health in ObesityNA
COMPLETED·NCT06279780 · Celia Bañuls
Obesity Adult Onset
very low-calorie diet
Efficacy of a Nutritional Education Strategy and Physical Exercise on the Gut Microbiota in Type 2 DiabeticsNA
UNKNOWN·NCT05261373 · University of Cadiz
Diabetes Mellitus, Type 2 Cardiovascular Diseases Fat Burn
The Moderate-Intensity Continuous Training (MICT) The High-Intensity Interval Training (HIIT) Behavioral: Nutritional education program
Effects of Exercise During Gestation on Maternal and Foetal HealthNA
COMPLETED·NCT02582567 · Universidad de Granada
Pregnancy
Exercise intervention Control group
Skeletal Muscle Mitochondria in AgeingUnknown
RECRUITING·NCT06539078 · VU University of Amsterdam
Aging
Maximal exercise test 3D Ultrasound Dynamometry

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for DRP1,MFN1,MFN2,CDK5,PRKCD,PARK2,PTEN,PGC1A,OPA1 →

No DepMap CRISPR Chronos data found for DRP1,MFN1,MFN2,CDK5,PRKCD,PARK2,PTEN,PGC1A,OPA1.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▼ 0.0%
Volatility
High
0.0973
Events (7d)
4
Price History
▼2.3%

💾 Resource Usage

No resource usage or linked notebooks recorded for this hypothesis yet.

🔮 Predictions

🔎 Predictions vs Observations2 predictions · 0 with recorded observations
PredictionPredictedObservedStatusConf
IF DRP1 S616 phosphorylation is chronically blocked via neuronal-specific CDK5 knockdown in 3-month-old A53T α-synuclein mice (PRKCD upregulation model), THEN mitochondrial network fragmentation will Aspect ratio ≥2.5 (vs. <1.5 in untreated A53T); MFN2 ≥80% of wild-type levels; mtROS ≤1.5-fold baseline— no observation —pending0.68
IF AAV9-MFN2 overexpression combined with Mdivi-1 (DRP1 inhibitor) is administered to 6-month-old 5xFAD mice via bilateral hippocampal injection, THEN cortical and hippocampal SA-β-gal positivity will≥40% reduction in SA-β-gal+ neurons; ≥70% restoration of Complex I activity; ≥25% increase in synaptic density— no observation —pending0.72
🔮 Falsifiable Predictions (2)
pendingconf 72%
IF AAV9-MFN2 overexpression combined with Mdivi-1 (DRP1 inhibitor) is administered to 6-month-old 5xFAD mice via bilateral hippocampal injection, THEN cortical and hippocampal SA-β-gal positivity will decrease by ≥40%, Complex I activity will restore to ≥70% of wild-type levels, and PSD95+ synaptic
Predicted outcome: ≥40% reduction in SA-β-gal+ neurons; ≥70% restoration of Complex I activity; ≥25% increase in synaptic density
Falsification: No significant change or increase in SA-β-gal positivity; Complex I activity remaining <50% of wild-type; synaptic density unchanged or decreased despite dual intervention; indicates the fission-fusio
pendingconf 68%
IF DRP1 S616 phosphorylation is chronically blocked via neuronal-specific CDK5 knockdown in 3-month-old A53T α-synuclein mice (PRKCD upregulation model), THEN mitochondrial network fragmentation will be prevented (mean aspect ratio ≥2.5), MFN2 protein levels will remain ≥80% of non-transgenic contro
Predicted outcome: Aspect ratio ≥2.5 (vs. <1.5 in untreated A53T); MFN2 ≥80% of wild-type levels; mtROS ≤1.5-fold baseline
Falsification: MFN2 protein still decreases despite DRP1 S616 inhibition, indicating p53-mediated MFN2 repression operates independently of fission-fusion imbalance; or mtROS remains >2-fold elevated, indicating the
View on SciDEX ↗